Loading…

265TiP SOLTI-2201 ACROSS-TROP2 trial: A phase II study to identify predictive biomarkers of sacituzumab govitecan benefit and to understand resistance mechanisms in HR+/HER2- advanced or metastatic breast cancer

Saved in:

Bibliographic Details
Published in:	ESMO open 2024-05, Vol.9, p.103286, Article 103286
Main Authors:	Ciruelos, E.M., Pascual, T., Vazquez, R. Villanueva, Cejalvo, J.M., Parraga, K. Amillano, Bofill, F.J. Salvador, López-Barajas, I. Blancas, Diez, A. Ferrando, Peron, Y. Izarzugaza, Puy, M. Borrell, Fernandez-Martinez, A., Javierre, G. Villacampa, Ferrero-Cafiero, J.M., Dias, M. Paes, Salvador, F., Oliveira, M.
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!